| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 5.08e-06 | 5 | 161 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 7.17e-05 | 28 | 161 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.75e-04 | 35 | 161 | 4 | GO:0015020 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.79e-05 | 21 | 158 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.35e-05 | 26 | 158 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.35e-05 | 26 | 158 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 5.83e-05 | 2 | 158 | 2 | GO:0006789 | |
| Domain | C2 | 1.48e-06 | 131 | 155 | 9 | PF00168 | |
| Domain | C2 | 2.15e-06 | 137 | 155 | 9 | SM00239 | |
| Domain | C2 | 2.89e-06 | 142 | 155 | 9 | PS50004 | |
| Domain | - | 4.06e-06 | 148 | 155 | 9 | 2.60.40.150 | |
| Domain | - | SEMA6B SEMA4B IFT140 CHAF1B PLXNB2 DENND3 FZR1 AAAS PLAA TECPR2 PLXNC1 DNAI4 DYNC1I2 | 4.29e-06 | 333 | 155 | 13 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | SEMA6B SEMA4B IFT140 CHAF1B PLXNB2 DENND3 FZR1 AAAS PLAA TECPR2 PLXNC1 DNAI4 DYNC1I2 | 4.58e-06 | 335 | 155 | 13 | IPR015943 |
| Domain | ARM-type_fold | DOCK1 NCAPD3 ZNFX1 XPO1 TEX10 TRRAP VIRMA JUP ATP6V1H PLAA DIAPH1 DIAPH2 PRKDC | 5.20e-06 | 339 | 155 | 13 | IPR016024 |
| Domain | C2_dom | 9.37e-06 | 164 | 155 | 9 | IPR000008 | |
| Domain | UDPGT | 2.45e-05 | 21 | 155 | 4 | PF00201 | |
| Domain | UDPGT | 2.45e-05 | 21 | 155 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 2.45e-05 | 21 | 155 | 4 | IPR002213 | |
| Domain | DUF4599 | 1.17e-04 | 12 | 155 | 3 | PF15371 | |
| Domain | DUF4599 | 1.17e-04 | 12 | 155 | 3 | IPR027970 | |
| Domain | HEAT | 1.19e-04 | 58 | 155 | 5 | IPR000357 | |
| Domain | Semap_dom | 1.21e-04 | 31 | 155 | 4 | IPR001627 | |
| Domain | SEMA | 1.21e-04 | 31 | 155 | 4 | PS51004 | |
| Domain | Sema | 1.21e-04 | 31 | 155 | 4 | SM00630 | |
| Domain | Sema | 1.21e-04 | 31 | 155 | 4 | PF01403 | |
| Domain | Plexin_repeat | 1.37e-04 | 32 | 155 | 4 | IPR002165 | |
| Domain | PSI | 1.37e-04 | 32 | 155 | 4 | PF01437 | |
| Domain | Drf_DAD | 2.04e-04 | 3 | 155 | 2 | PF06345 | |
| Domain | Drf_DAD | 2.04e-04 | 3 | 155 | 2 | IPR010465 | |
| Domain | - | 2.04e-04 | 3 | 155 | 2 | 4.10.1130.10 | |
| Domain | - | 2.90e-04 | 16 | 155 | 3 | 1.10.506.10 | |
| Domain | WD40 | 4.10e-04 | 268 | 155 | 9 | SM00320 | |
| Domain | RasGAP_dom | 4.17e-04 | 18 | 155 | 3 | IPR001936 | |
| Domain | WD40_repeat | 4.56e-04 | 272 | 155 | 9 | IPR001680 | |
| Domain | PSI | 4.78e-04 | 44 | 155 | 4 | IPR016201 | |
| Domain | VWC_out | 4.93e-04 | 19 | 155 | 3 | SM00215 | |
| Domain | WD_REPEATS_1 | 5.34e-04 | 278 | 155 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.48e-04 | 279 | 155 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.48e-04 | 279 | 155 | 9 | PS50294 | |
| Domain | PSI | 5.68e-04 | 46 | 155 | 4 | SM00423 | |
| Domain | HEAT | 6.68e-04 | 48 | 155 | 4 | PF02985 | |
| Domain | Anaphylatoxin_comp_syst | 6.73e-04 | 5 | 155 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 6.73e-04 | 5 | 155 | 2 | IPR001840 | |
| Domain | Mab-21-like_1/2 | 6.73e-04 | 5 | 155 | 2 | IPR020950 | |
| Domain | WD40_repeat_dom | 8.55e-04 | 297 | 155 | 9 | IPR017986 | |
| Domain | FAT | 1.00e-03 | 6 | 155 | 2 | PS51189 | |
| Domain | FATC | 1.00e-03 | 6 | 155 | 2 | PS51190 | |
| Domain | FAT | 1.00e-03 | 6 | 155 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.00e-03 | 6 | 155 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.00e-03 | 6 | 155 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.00e-03 | 6 | 155 | 2 | IPR014009 | |
| Domain | FATC | 1.00e-03 | 6 | 155 | 2 | SM01343 | |
| Domain | - | UBR2 MARCHF9 RC3H1 NSD1 RNF43 RPH3A SYTL3 HLTF KDM2A MARCHF4 DNMT3L | 1.34e-03 | 449 | 155 | 11 | 3.30.40.10 |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 1.40e-03 | 7 | 155 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.40e-03 | 7 | 155 | 2 | PS01177 | |
| Domain | ANATO | 1.40e-03 | 7 | 155 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 1.40e-03 | 7 | 155 | 2 | IPR000020 | |
| Domain | WD40 | 1.46e-03 | 259 | 155 | 8 | PF00400 | |
| Domain | Znf_RING/FYVE/PHD | UBR2 MARCHF9 RC3H1 NSD1 RNF43 RPH3A SYTL3 HLTF KDM2A MARCHF4 DNMT3L | 1.59e-03 | 459 | 155 | 11 | IPR013083 |
| Domain | DAD_dom | 1.85e-03 | 8 | 155 | 2 | IPR014767 | |
| Domain | MARCH-like | 1.85e-03 | 8 | 155 | 2 | IPR033275 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.85e-03 | 8 | 155 | 2 | IPR019565 | |
| Domain | DAD | 1.85e-03 | 8 | 155 | 2 | PS51231 | |
| Domain | Thiol-ester_cl | 1.85e-03 | 8 | 155 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.85e-03 | 8 | 155 | 2 | IPR019742 | |
| Domain | ARM-like | 1.90e-03 | 270 | 155 | 8 | IPR011989 | |
| Domain | Ig-like_fold | SLAMF8 SEMA4B STBD1 PECAM1 FNDC3A MDGA2 PLXNB2 RIMBP3 GHR PLXNC1 CD101 RIMBP3C FCRL4 RIMBP3B | 2.28e-03 | 706 | 155 | 14 | IPR013783 |
| Domain | BTK | 2.37e-03 | 9 | 155 | 2 | SM00107 | |
| Domain | Plexin_cytopl | 2.37e-03 | 9 | 155 | 2 | PF08337 | |
| Domain | Drf_GBD | 2.37e-03 | 9 | 155 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.37e-03 | 9 | 155 | 2 | PF06367 | |
| Domain | Znf_Btk_motif | 2.37e-03 | 9 | 155 | 2 | IPR001562 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 2.37e-03 | 9 | 155 | 2 | IPR013548 | |
| Domain | FH3_dom | 2.37e-03 | 9 | 155 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.37e-03 | 9 | 155 | 2 | IPR010473 | |
| Domain | Plexin | 2.37e-03 | 9 | 155 | 2 | IPR031148 | |
| Domain | BTK | 2.37e-03 | 9 | 155 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.37e-03 | 9 | 155 | 2 | PS51113 | |
| Domain | Drf_FH3 | 2.37e-03 | 9 | 155 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.37e-03 | 9 | 155 | 2 | SM01140 | |
| Domain | - | 2.57e-03 | 222 | 155 | 7 | 1.25.10.10 | |
| Domain | HEAT_REPEAT | 2.74e-03 | 70 | 155 | 4 | PS50077 | |
| Domain | A2M | 2.95e-03 | 10 | 155 | 2 | PF00207 | |
| Domain | A2M_N_2 | 2.95e-03 | 10 | 155 | 2 | IPR011625 | |
| Domain | A2M_comp | 2.95e-03 | 10 | 155 | 2 | IPR011626 | |
| Domain | A2M_recep | 2.95e-03 | 10 | 155 | 2 | PF07677 | |
| Domain | A2M_comp | 2.95e-03 | 10 | 155 | 2 | PF07678 | |
| Domain | A2M_N | 2.95e-03 | 10 | 155 | 2 | PF01835 | |
| Domain | A2M_N | 2.95e-03 | 10 | 155 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.95e-03 | 10 | 155 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.95e-03 | 10 | 155 | 2 | PS00477 | |
| Domain | A2M_N_2 | 2.95e-03 | 10 | 155 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 2.95e-03 | 10 | 155 | 2 | IPR001599 | |
| Domain | GPS | 3.02e-03 | 35 | 155 | 3 | PF01825 | |
| Domain | GPS | 3.27e-03 | 36 | 155 | 3 | PS50221 | |
| Domain | GPS | 3.54e-03 | 37 | 155 | 3 | IPR000203 | |
| Domain | GBD/FH3_dom | 3.58e-03 | 11 | 155 | 2 | IPR014768 | |
| Domain | ZF_RING_CH | 3.58e-03 | 11 | 155 | 2 | PS51292 | |
| Domain | GBD_FH3 | 3.58e-03 | 11 | 155 | 2 | PS51232 | |
| Domain | FYVE_2 | 3.58e-03 | 11 | 155 | 2 | PF02318 | |
| Domain | RINGv | 3.58e-03 | 11 | 155 | 2 | PF12906 | |
| Domain | VWC | 3.82e-03 | 38 | 155 | 3 | SM00214 | |
| Domain | SH3_9 | 4.04e-03 | 78 | 155 | 4 | PF14604 | |
| Domain | Mab-21 | 4.28e-03 | 12 | 155 | 2 | PF03281 | |
| Domain | Mab-21 | 4.28e-03 | 12 | 155 | 2 | SM01265 | |
| Domain | C8 | 4.28e-03 | 12 | 155 | 2 | PF08742 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.90e-05 | 20 | 116 | 4 | MM14721 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.07e-05 | 24 | 116 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.82e-05 | 25 | 116 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.82e-05 | 25 | 116 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.82e-05 | 25 | 116 | 4 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.66e-05 | 26 | 116 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 7.65e-05 | 28 | 116 | 4 | M19580 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.31e-04 | 32 | 116 | 4 | MM14719 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.30e-04 | 15 | 116 | 3 | MM15697 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 3.49e-04 | 41 | 116 | 4 | M7399 | |
| Pubmed | UBR2 NCAPD3 CHAF1B UGGT1 EIF3E XPO1 VIRMA SPCS3 PLAA ABCB10 OSBPL3 EIF3L DIAPH1 MRPS9 PRKDC DYNC1I2 | 5.78e-10 | 457 | 163 | 16 | 22190034 | |
| Pubmed | 6.92e-09 | 6 | 163 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.92e-09 | 6 | 163 | 4 | 25930072 | |
| Pubmed | 1.61e-08 | 7 | 163 | 4 | 20870941 | ||
| Pubmed | 5.75e-08 | 9 | 163 | 4 | 22511988 | ||
| Pubmed | 5.75e-08 | 9 | 163 | 4 | 1339448 | ||
| Pubmed | 9.55e-08 | 10 | 163 | 4 | 23642732 | ||
| Pubmed | 9.55e-08 | 10 | 163 | 4 | 11465080 | ||
| Pubmed | 9.55e-08 | 10 | 163 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 9.55e-08 | 10 | 163 | 4 | 22558097 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 12051676 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 21383159 | ||
| Pubmed | 2.24e-07 | 12 | 163 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.24e-07 | 12 | 163 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.22e-07 | 13 | 163 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.22e-07 | 13 | 163 | 4 | 25246029 | |
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 4.03e-07 | 4 | 163 | 3 | 18223459 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 9535849 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 24239357 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 4.03e-07 | 4 | 163 | 3 | 19091768 | |
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.49e-07 | 14 | 163 | 4 | 10836148 | |
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.49e-07 | 14 | 163 | 4 | 14672974 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 8.10e-07 | 16 | 163 | 4 | 19414484 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 26554163 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 7677729 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 1.00e-06 | 5 | 163 | 3 | 17855024 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.06e-06 | 17 | 163 | 4 | 20639394 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EIF3E TTC27 XPO1 RFC1 TEX10 TRRAP GTF3C5 MEMO1 JUP AAAS PLAA ERAL1 EIF3L DIAPH1 HLTF PRKCA KDM2A DDX60L PRKDC ZMYM3 DYNC1I2 | 1.58e-06 | 1353 | 163 | 21 | 29467282 |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.71e-06 | 19 | 163 | 4 | 23281178 | |
| Pubmed | Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. | 2.00e-06 | 6 | 163 | 3 | 17212707 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 2.00e-06 | 6 | 163 | 3 | 19204906 | |
| Pubmed | STBD1 CCDC174 TMEM94 UGGT1 EIF3E FNDC3A SPG11 CWC25 GTF3C5 CEMIP2 GLMN AAAS EIF3L TNRC6A DIAPH1 | 2.10e-06 | 733 | 163 | 15 | 34672954 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 DYNC2H1 TTC27 FNDC3A XPO1 TEX10 PLXNB2 RNF43 GLMN SPCS3 ATP6V1H AAAS PLAA ABCB10 EIF3L PRKDC ZMYM3 | 2.34e-06 | 942 | 163 | 17 | 31073040 |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 3.49e-06 | 7 | 163 | 3 | 8467709 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 8464825 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | NCAPD3 EIF3E FNDC3A SLFN5 XPO1 TEX10 PLXNB2 VIRMA CEMIP2 SPCS3 JUP ATP6V1H AAAS ABCB10 EIF3L CENPI GHITM PRKDC ZMYM3 | 4.04e-06 | 1203 | 163 | 19 | 29180619 |
| Pubmed | SEMA4B DYNC2H1 RC3H1 ATP8B2 DENND3 NPHP3 SSH1 SACS OSBPL3 SBF2 KDM2A UTP14C | 4.05e-06 | 493 | 163 | 12 | 15368895 | |
| Pubmed | 4.59e-06 | 24 | 163 | 4 | 32212159 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 4.59e-06 | 24 | 163 | 4 | 24625756 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6B SEMA4B TMEM94 INPPL1 NSD1 PLXNB2 TRRAP CIT CHRM4 RNF43 FZR1 C2CD3 CYREN SSH1 PLA2G4B SBF2 DIAPH2 PRKDC | 4.83e-06 | 1105 | 163 | 18 | 35748872 |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 20610558 | ||
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 22579593 | ||
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 17179145 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 5.56e-06 | 8 | 163 | 3 | 12695355 | |
| Pubmed | TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. | 8.72e-06 | 28 | 163 | 4 | 29653964 | |
| Pubmed | 8.97e-06 | 102 | 163 | 6 | 10231032 | ||
| Pubmed | UBR2 MYO1D UGGT1 CAMSAP3 TTC27 KIAA1549 XPO1 TEX10 CEMIP2 GLMN C2CD3 AAAS SSH1 MTUS1 SBF2 TNRC6A DMD | 9.63e-06 | 1049 | 163 | 17 | 27880917 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.00e-05 | 104 | 163 | 6 | 31240132 | |
| Pubmed | MICAL1 MYO1D CAMSAP3 KIAA1549 ZNFX1 XPO1 CIT VIRMA RPH3A JUP ATP6V1H SACS EIF3L STON2 MRPS9 PRKCA C4A C4B LRRC7 DMD | 1.34e-05 | 1431 | 163 | 20 | 37142655 | |
| Pubmed | 1.51e-05 | 66 | 163 | 5 | 19898482 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.16e-05 | 12 | 163 | 3 | 20308471 | |
| Pubmed | 2.16e-05 | 12 | 163 | 3 | 18161889 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.18e-05 | 2 | 163 | 2 | 16565498 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15998580 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.18e-05 | 2 | 163 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.18e-05 | 2 | 163 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.18e-05 | 2 | 163 | 2 | 17645767 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 28402280 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8068691 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17668421 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12207352 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24486332 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.18e-05 | 2 | 163 | 2 | 27758680 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22387014 | ||
| Pubmed | Mouse germ cell-less as an essential component for nuclear integrity. | 2.18e-05 | 2 | 163 | 2 | 12556490 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 2.18e-05 | 2 | 163 | 2 | 11448776 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 14992721 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.18e-05 | 2 | 163 | 2 | 23749435 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.18e-05 | 2 | 163 | 2 | 3037333 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 11726230 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 4216347 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24641623 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.18e-05 | 2 | 163 | 2 | 6950384 | |
| Pubmed | Memo is a copper-dependent redox protein with an essential role in migration and metastasis. | 2.18e-05 | 2 | 163 | 2 | 24917593 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.18e-05 | 2 | 163 | 2 | 8428773 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38781210 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.18e-05 | 2 | 163 | 2 | 21345967 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 2572548 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 2302180 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.18e-05 | 2 | 163 | 2 | 18091514 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 29080553 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.18e-05 | 2 | 163 | 2 | 25339671 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 17728371 | ||
| Pubmed | The Notch ligand Jagged1 is required for inner ear sensory development. | 2.18e-05 | 2 | 163 | 2 | 11259677 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 6149580 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 6149581 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 21854253 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12115608 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 3542363 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 2387317 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16908004 | ||
| Interaction | RBM3 interactions | TMEM94 RC3H1 XPO1 MAB21L2 TRRAP CIT VIRMA FZR1 JUP MRPS9 DDX60L | 5.85e-08 | 163 | 156 | 11 | int:RBM3 |
| Interaction | CENPA interactions | NSD1 XPO1 RFC1 TEX10 TRRAP VIRMA GTF3C5 CENPI DIAPH1 DIAPH2 HLTF KDM2A PRKDC ZMYM3 | 1.45e-06 | 377 | 156 | 14 | int:CENPA |
| Interaction | OPALIN interactions | NCAPD3 TTC27 SLFN5 ATP6V1H AAAS PLAA GHITM PRKCA PRKDC DOP1B | 5.46e-06 | 209 | 156 | 10 | int:OPALIN |
| Interaction | SSH2 interactions | 1.98e-05 | 43 | 156 | 5 | int:SSH2 | |
| Cytoband | 2q37 | 4.47e-06 | 31 | 163 | 4 | 2q37 | |
| Cytoband | 2p22-p21 | 3.46e-04 | 8 | 163 | 2 | 2p22-p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.46e-04 | 8 | 163 | 2 | chr9q12 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 1.97e-05 | 10 | 101 | 3 | 822 | |
| GeneFamily | UDP glucuronosyltransferases | 2.93e-05 | 32 | 101 | 4 | 363 | |
| GeneFamily | WD repeat domain containing | 1.10e-04 | 262 | 101 | 8 | 362 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.08e-03 | 9 | 101 | 2 | 1234 | |
| GeneFamily | Plexins | 1.08e-03 | 9 | 101 | 2 | 683 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.35e-03 | 10 | 101 | 2 | 830 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 1.64e-03 | 11 | 101 | 2 | 60 | |
| GeneFamily | Dyneins, cytoplasmic | 2.32e-03 | 13 | 101 | 2 | 538 | |
| GeneFamily | Eukaryotic translation initiation factor 3 | 2.32e-03 | 13 | 101 | 2 | 1121 | |
| GeneFamily | Immunoglobulin like domain containing | 4.56e-03 | 193 | 101 | 5 | 594 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.97e-03 | 19 | 101 | 2 | 832 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 5.50e-03 | 20 | 101 | 2 | 736 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 4.09e-06 | 200 | 160 | 9 | M8030 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | 4.09e-06 | 200 | 160 | 9 | M7978 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-07 | 130 | 161 | 7 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 158 | 161 | 7 | 9f0987eaf1766aadb5714b68df7a5d310ea5a57a | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-06 | 175 | 161 | 7 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-06 | 175 | 161 | 7 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 178 | 161 | 7 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-06 | 183 | 161 | 7 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.25e-06 | 191 | 161 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-06 | 192 | 161 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.69e-06 | 193 | 161 | 7 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 194 | 161 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.16e-06 | 195 | 161 | 7 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.17e-06 | 199 | 161 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-06 | 134 | 161 | 6 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 163 | 161 | 6 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | facs-BAT-Fat-3m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-05 | 164 | 161 | 6 | cbdb7e893cb3959b9920c0c7c535ace03a5f4986 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 170 | 161 | 6 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 170 | 161 | 6 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-05 | 170 | 161 | 6 | af8b56555cbd5a1016ab9ec2ce88225c58c89648 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.86e-05 | 172 | 161 | 6 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | 3c51e7bda1835c25915e50c801b0d643979971a3 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 173 | 161 | 6 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | 889a880de5fc19d26b82cfef3067869a28ef17ca | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 173 | 161 | 6 | a042f78a4c69fcc6b5ca76e9bf01e34cee54c81c | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 173 | 161 | 6 | 01df9baeedf30e3a4891738554cdd300394dbb96 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-05 | 177 | 161 | 6 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 177 | 161 | 6 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | 41745a589567ca5ea6d06331f4c8da03595b5f5c | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 178 | 161 | 6 | eb940dd64c973f68bcaad6069d3bd56383329db5 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.82e-05 | 179 | 161 | 6 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.82e-05 | 179 | 161 | 6 | 0624dd537a68736f4d7b8b4de2c56168ed0e60a9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.82e-05 | 179 | 161 | 6 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 180 | 161 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 180 | 161 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.62e-05 | 184 | 161 | 6 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.79e-05 | 185 | 161 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.79e-05 | 185 | 161 | 6 | 94d0f283d63d932f310cc5a17ea893d71ba60f5e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.96e-05 | 186 | 161 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 187 | 161 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.52e-05 | 189 | 161 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 192 | 161 | 6 | eafead22bba48ac5ee568faa8946c444445c1034 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.31e-05 | 193 | 161 | 6 | 792315f409a57fa6a8a88c850060b1e089e062ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-05 | 194 | 161 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-05 | 194 | 161 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-05 | 194 | 161 | 6 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.53e-05 | 194 | 161 | 6 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.19e-05 | 197 | 161 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.19e-05 | 197 | 161 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 161 | 6 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.19e-05 | 197 | 161 | 6 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | ILEUM-non-inflamed-(7)_ACKR1+_endothelial_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.42e-05 | 198 | 161 | 6 | f8a6a75c9f2fbe32a22b14b6a029411c73c09f68 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 123 | 161 | 5 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 199 | 161 | 6 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 8.90e-05 | 200 | 161 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.90e-05 | 200 | 161 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 8.90e-05 | 200 | 161 | 6 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.90e-05 | 200 | 161 | 6 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 8.90e-05 | 200 | 161 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-04 | 132 | 161 | 5 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 136 | 161 | 5 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 136 | 161 | 5 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Crh|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.36e-04 | 136 | 161 | 5 | 44f03e4f55fb2c5f8b9397142c89f7194b009cc6 | |
| Drug | AC1MRQNQ | 2.41e-07 | 9 | 153 | 4 | CID003522271 | |
| Drug | DHPASiU | 2.41e-07 | 9 | 153 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 2.41e-07 | 9 | 153 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 2.41e-07 | 9 | 153 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 2.41e-07 | 9 | 153 | 4 | CID005460873 | |
| Drug | 5,6-benzoquinoline | 6.12e-07 | 25 | 153 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 6.12e-07 | 25 | 153 | 5 | CID000013662 | |
| Drug | 4-nitrophenyl)imidazole | 6.24e-07 | 11 | 153 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 6.24e-07 | 11 | 153 | 4 | CID006442661 | |
| Drug | NSC302991 | GPLD1 CHAF1B NEIL2 UGT1A5 XPO1 CIT UGT1A4 UGT1A1 UGT1A3 ABCB10 JAG1 ABCD4 PRKDC | 8.17e-07 | 353 | 153 | 13 | CID000002538 |
| Drug | erythromycin stearate | 8.51e-07 | 111 | 153 | 8 | CID000012559 | |
| Drug | N-OH-DABZ | 9.31e-07 | 12 | 153 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 9.31e-07 | 12 | 153 | 4 | CID000088735 | |
| Drug | 2,4,6-TCB | 9.31e-07 | 12 | 153 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 9.31e-07 | 12 | 153 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 9.31e-07 | 12 | 153 | 4 | CID000276709 | |
| Drug | H-Ni | 1.11e-06 | 28 | 153 | 5 | CID000445665 | |
| Drug | (+/-)-Abacavir | 1.17e-06 | 51 | 153 | 6 | CID000001971 | |
| Drug | Finrazole | 1.17e-06 | 51 | 153 | 6 | CID000178036 | |
| Drug | tritanol | 1.34e-06 | 13 | 153 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.34e-06 | 13 | 153 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.34e-06 | 13 | 153 | 4 | CID000000411 | |
| Drug | propranolol glucuronide | 1.86e-06 | 14 | 153 | 4 | CID000119515 | |
| Drug | PCB-61 | 1.86e-06 | 14 | 153 | 4 | CID000036401 | |
| Drug | PCB 156 | 1.89e-06 | 31 | 153 | 5 | CID000038019 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.53e-06 | 15 | 153 | 4 | CID000040469 | |
| Drug | afloqualone | 2.53e-06 | 15 | 153 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 2.53e-06 | 15 | 153 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 2.53e-06 | 15 | 153 | 4 | CID000010752 | |
| Drug | sulforaphane nitrile | 2.53e-06 | 15 | 153 | 4 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 3.35e-06 | 16 | 153 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 3.35e-06 | 16 | 153 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 3.35e-06 | 16 | 153 | 4 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 4.36e-06 | 17 | 153 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 4.36e-06 | 17 | 153 | 4 | CID000037766 | |
| Drug | TBHQ | 5.15e-06 | 141 | 153 | 8 | CID000016043 | |
| Drug | acacetin | 5.39e-06 | 38 | 153 | 5 | CID005280442 | |
| Drug | ethoxytriethyleneglycol | 5.44e-06 | 66 | 153 | 6 | CID000008190 | |
| Drug | SureCN12722713 | 5.58e-06 | 18 | 153 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 5.58e-06 | 18 | 153 | 4 | CID000152226 | |
| Drug | Br 2 | 5.58e-06 | 18 | 153 | 4 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 5.58e-06 | 18 | 153 | 4 | CID000036614 | |
| Drug | ApApG | 5.58e-06 | 18 | 153 | 4 | CID003081975 | |
| Drug | C1 11-32 | 5.58e-06 | 18 | 153 | 4 | CID000443077 | |
| Drug | C11131 | 5.58e-06 | 18 | 153 | 4 | CID000443076 | |
| Drug | 9-OH-risperidone | 7.02e-06 | 19 | 153 | 4 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 7.02e-06 | 19 | 153 | 4 | CID000091433 | |
| Drug | almokalant | 7.02e-06 | 19 | 153 | 4 | CID003033962 | |
| Drug | tectochrysin | 8.74e-06 | 20 | 153 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 8.74e-06 | 20 | 153 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 8.74e-06 | 20 | 153 | 4 | CID000116545 | |
| Drug | 7,8-benzoquinoline | 1.01e-05 | 43 | 153 | 5 | CID000009191 | |
| Drug | ranirestat | 1.02e-05 | 7 | 153 | 3 | ctd:C115070 | |
| Drug | estriol-16-glucuronide | 1.07e-05 | 21 | 153 | 4 | CID000122281 | |
| Drug | dulcin | 1.07e-05 | 21 | 153 | 4 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.07e-05 | 21 | 153 | 4 | CID000069186 | |
| Drug | amonafide | 1.31e-05 | 22 | 153 | 4 | CID000050515 | |
| Drug | N-methylpiperazine | 1.31e-05 | 22 | 153 | 4 | CID000053167 | |
| Drug | amidoxime | 1.57e-05 | 23 | 153 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 1.57e-05 | 23 | 153 | 4 | CID000066651 | |
| Drug | phenanthridine | 1.57e-05 | 23 | 153 | 4 | CID000009189 | |
| Drug | retigabine | 1.74e-05 | 48 | 153 | 5 | CID000121892 | |
| Drug | AS-3201 | 1.88e-05 | 24 | 153 | 4 | CID000153948 | |
| Drug | 5-MOP | 2.22e-05 | 25 | 153 | 4 | CID000002355 | |
| Drug | AzMC | 2.22e-05 | 25 | 153 | 4 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.22e-05 | 25 | 153 | 4 | CID000018787 | |
| Drug | 1-hydroxypyrene | 2.35e-05 | 51 | 153 | 5 | ctd:C033146 | |
| Drug | ASA404 | 2.84e-05 | 53 | 153 | 5 | CID000123964 | |
| Drug | diflunisal | 3.05e-05 | 27 | 153 | 4 | CID000003059 | |
| Drug | DiMeIQx | 3.05e-05 | 27 | 153 | 4 | CID000104739 | |
| Drug | 3-chlorobenzylamine | 3.48e-05 | 91 | 153 | 6 | CID000077802 | |
| Drug | CARMINE | 3.54e-05 | 28 | 153 | 4 | CID000014749 | |
| Drug | erucin | 3.54e-05 | 28 | 153 | 4 | CID000078160 | |
| Drug | N-hydroxy-4-aminobiphenyl | 3.54e-05 | 28 | 153 | 4 | CID000081261 | |
| Drug | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | 3.54e-05 | 28 | 153 | 4 | ctd:C025984 | |
| Drug | Invader | 3.72e-05 | 56 | 153 | 5 | CID006442259 | |
| Drug | AC1L1JAL | 4.09e-05 | 29 | 153 | 4 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 4.09e-05 | 29 | 153 | 4 | CID000125641 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 4.09e-05 | 29 | 153 | 4 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 4.09e-05 | 29 | 153 | 4 | CID000000414 | |
| Drug | iberin | 4.09e-05 | 29 | 153 | 4 | CID000010455 | |
| Drug | afloqualone | 4.49e-05 | 2 | 153 | 2 | ctd:C033541 | |
| Drug | tolcapone | 4.69e-05 | 30 | 153 | 4 | CID004659569 | |
| Drug | paricalcitol | 4.69e-05 | 30 | 153 | 4 | CID005281104 | |
| Drug | AC1L9E0Q | 4.69e-05 | 30 | 153 | 4 | CID000443095 | |
| Drug | dihydroartemisinin | 4.69e-05 | 30 | 153 | 4 | CID000107770 | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 5.00e-05 | 193 | 153 | 8 | 6751_DN | |
| Drug | 4'-HPPH | 5.36e-05 | 31 | 153 | 4 | CID000017732 | |
| Drug | 4-ethylphenol | 5.36e-05 | 31 | 153 | 4 | CID000031242 | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 7031_DN | |
| Drug | SC 19220; Up 200; 10uM; PC3; HT_HG-U133A | 5.99e-05 | 198 | 153 | 8 | 7095_UP | |
| Drug | Muracein C | 6.09e-05 | 32 | 153 | 4 | CID003086323 | |
| Drug | indole-2-carboxylic acid | 6.09e-05 | 32 | 153 | 4 | CID000072899 | |
| Drug | NNAL | 6.09e-05 | 32 | 153 | 4 | CID000104856 | |
| Drug | AC1L7AJI | 6.09e-05 | 256 | 153 | 9 | CID000003750 | |
| Drug | 2-hydroxyestradiol | 6.59e-05 | 63 | 153 | 5 | CID000009684 | |
| Drug | R(-)-Denopamine | 6.89e-05 | 33 | 153 | 4 | CID000003818 | |
| Drug | norbuprenorphine | 6.89e-05 | 33 | 153 | 4 | CID000114976 | |
| Drug | AC1Q6OQG | 6.89e-05 | 33 | 153 | 4 | CID000009686 | |
| Drug | 6-methylsalicylic acid | 6.89e-05 | 33 | 153 | 4 | CID000011279 | |
| Disease | X-11442 measurement | 7.51e-08 | 9 | 148 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 7.51e-08 | 9 | 148 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 7.51e-08 | 9 | 148 | 4 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 7.51e-08 | 9 | 148 | 4 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.25e-07 | 10 | 148 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.25e-07 | 10 | 148 | 4 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 1.95e-07 | 11 | 148 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.95e-07 | 11 | 148 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.95e-07 | 11 | 148 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.95e-07 | 11 | 148 | 4 | EFO_0010219 | |
| Disease | biliverdin measurement | 2.92e-07 | 12 | 148 | 4 | EFO_0021033 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.37e-06 | 17 | 148 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-11793--oxidized bilirubin measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 6.80e-06 | 8 | 148 | 3 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.02e-05 | 9 | 148 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.02e-05 | 9 | 148 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.02e-05 | 9 | 148 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.02e-05 | 9 | 148 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.02e-05 | 9 | 148 | 3 | EFO_0802127 | |
| Disease | xanthurenate measurement | 1.31e-05 | 29 | 148 | 4 | EFO_0010551 | |
| Disease | X-21448 measurement | 1.45e-05 | 10 | 148 | 3 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.45e-05 | 10 | 148 | 3 | EFO_0800867 | |
| Disease | response to dolutegravir | 1.50e-05 | 30 | 148 | 4 | EFO_0600017 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.98e-05 | 11 | 148 | 3 | DOID:3717 (is_implicated_in) | |
| Disease | p-cresol glucuronide measurement | 2.63e-05 | 12 | 148 | 3 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 3.41e-05 | 13 | 148 | 3 | EFO_0802007 | |
| Disease | Saldino-Noonan Syndrome | 4.32e-05 | 14 | 148 | 3 | C0036069 | |
| Disease | autosomal dominant auditory neuropathy 1 (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0060690 (implicated_via_orthology) | |
| Disease | cholelithiasis | 8.31e-05 | 88 | 148 | 5 | EFO_0004799 | |
| Disease | angiopoietin-related protein 1 measurement | 9.55e-05 | 18 | 148 | 3 | EFO_0801382 | |
| Disease | Schizophrenia | NRIP1 TRRAP CHRM4 UGT1A3 PLAA PLA2G4B JAG1 STON2 PRKCA LTA ADGRF4 HCRTR1 DNMT3L GABRA5 | 1.51e-04 | 883 | 148 | 14 | C0036341 |
| Disease | tissue factor measurement | 1.54e-04 | 21 | 148 | 3 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 2.09e-04 | 58 | 148 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | Abnormality of head or neck | 2.47e-04 | 5 | 148 | 2 | C4021817 | |
| Disease | Autistic Disorder | 3.62e-04 | 261 | 148 | 7 | C0004352 | |
| Disease | Beckwith-Wiedemann Syndrome | 5.16e-04 | 7 | 148 | 2 | C0004903 | |
| Disease | Global developmental delay | 5.70e-04 | 133 | 148 | 5 | C0557874 | |
| Disease | endometrial cancer (is_implicated_in) | 7.82e-04 | 36 | 148 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Graves' disease (is_implicated_in) | 9.90e-04 | 39 | 148 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | neuroblastoma (is_implicated_in) | 1.10e-03 | 10 | 148 | 2 | DOID:769 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.32e-03 | 43 | 148 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 1.33e-03 | 11 | 148 | 2 | C0265275 | |
| Disease | pregnenetriol sulfate measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0600039 | |
| Disease | psoriatic arthritis (is_implicated_in) | 1.33e-03 | 11 | 148 | 2 | DOID:9008 (is_implicated_in) | |
| Disease | Congenital Heart Defects | 1.41e-03 | 44 | 148 | 3 | C0018798 | |
| Disease | Adenocarcinoma of large intestine | 1.41e-03 | 96 | 148 | 4 | C1319315 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0800573 | |
| Disease | Intestinal Neoplasms | 1.60e-03 | 12 | 148 | 2 | C0021841 | |
| Disease | Intestinal Cancer | 1.60e-03 | 12 | 148 | 2 | C0346627 | |
| Disease | autistic disorder (is_marker_for) | 1.60e-03 | 12 | 148 | 2 | DOID:12849 (is_marker_for) | |
| Disease | neutrophil count | UBR2 DYNC2H1 NEIL2 RC3H1 NSD1 XPO1 CIT ADGRG6 LGI2 CD101 SBF2 TNRC6A OLFM1 LTA PRKDC HCRTR1 | 1.60e-03 | 1382 | 148 | 16 | EFO_0004833 |
| Disease | Short Rib-Polydactyly Syndrome | 1.88e-03 | 13 | 148 | 2 | C0036996 | |
| Disease | pregnenetriol disulfate measurement | 1.88e-03 | 13 | 148 | 2 | EFO_0800587 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.88e-03 | 13 | 148 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.88e-03 | 13 | 148 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.88e-03 | 13 | 148 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.88e-03 | 13 | 148 | 2 | C0019147 | |
| Disease | Intellectual Disability | 1.94e-03 | 447 | 148 | 8 | C3714756 | |
| Disease | gallstones | 2.17e-03 | 108 | 148 | 4 | EFO_0004210 | |
| Disease | Majewski Syndrome | 2.19e-03 | 14 | 148 | 2 | C0024507 | |
| Disease | ovarian cancer (is_implicated_in) | 2.82e-03 | 56 | 148 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Cocaine-Related Disorders | 2.91e-03 | 117 | 148 | 4 | C0236736 | |
| Disease | Polydactyly | 2.91e-03 | 117 | 148 | 4 | C0152427 | |
| Disease | serum urea measurement | 3.09e-03 | 195 | 148 | 5 | EFO_0009795 | |
| Disease | X-21441 measurement | 3.23e-03 | 17 | 148 | 2 | EFO_0800814 | |
| Disease | insulin resistance | 3.27e-03 | 59 | 148 | 3 | EFO_0002614 | |
| Disease | uric acid measurement | 3.76e-03 | 610 | 148 | 9 | EFO_0004761 | |
| Disease | Cocaine Abuse | 3.90e-03 | 127 | 148 | 4 | C0009171 | |
| Disease | X-11470 measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0021241 | |
| Disease | inosine measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0010503 | |
| Disease | pulse pressure measurement | NRIP1 DYNC2H1 SETD6 FAT3 PECAM1 PKD1L3 PLXNB2 RPH3A JUP PLXNC1 JAG1 SBF2 TNRC6A LTA PLCE1 | 4.38e-03 | 1392 | 148 | 15 | EFO_0005763 |
| Disease | body weight | DOCK1 GTF2A1L SETD6 MDGA2 TEX10 VIRMA RPH3A ADGRG6 GHR TNRC6A KCNQ1 KDM2A DMD DYNC1I2 | 4.54e-03 | 1261 | 148 | 14 | EFO_0004338 |
| Disease | hypertension | 4.64e-03 | 307 | 148 | 6 | EFO_0000537 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TRPSNLANNTILVKW | 341 | P35503 | |
| RALNPASRWSKIQIV | 331 | P08173 | |
| TLLLWQVRLKSNRPS | 466 | P0CF97 | |
| RLQRNVASLAWKPLS | 191 | Q9NRG9 | |
| ANLNPVTWIKTIRST | 511 | O42043 | |
| WIGNSLKPDSVRSQL | 81 | Q8NHP1 | |
| LNLKKSWHPQTLRNV | 6 | Q9NXE8 | |
| NNSWRKLNLENIPRT | 201 | Q96LI9 | |
| SPEKLQETSNWLLSQ | 1096 | P0C0L5 | |
| SLQNAVRVWSNIPAI | 316 | Q9UJW3 | |
| WNIPNLALKAESNLS | 341 | Q86SQ4 | |
| NRKIVRNLWQSSRPL | 1156 | Q7Z2Y8 | |
| NILSISNKSWDLLIP | 141 | Q96PJ5 | |
| RKLWPNASQAISIAF | 281 | Q8IZF3 | |
| LNTLQAWSKTTPRRI | 486 | Q13112 | |
| WLRLKIQSENVPNAT | 41 | Q99758 | |
| LNPVWLRSKIGTVSQ | 561 | Q9NRK6 | |
| KQTNLQWIKVSRALP | 2296 | P11532 | |
| QILKVLFPSWSSQNA | 26 | O14678 | |
| ESLRVSLNNNPVSWV | 166 | O60610 | |
| LRVSLTSNPVSWVNN | 186 | O60879 | |
| WNVSTLQVTSRFQLP | 1016 | A2RUS2 | |
| KAWNRQLSRPLSQAV | 391 | Q9P1Y5 | |
| VRTPLSQVNKVWDQS | 2011 | O14578 | |
| AQNTLAQPTVWLTIV | 1076 | P98198 | |
| QLVPSWNGSLKQLLT | 286 | Q96IK5 | |
| PQQLSSNLWAAVRAR | 176 | Q5TC82 | |
| LNQWLSALRKVSINN | 661 | O43374 | |
| EPLTWAQLNKLTQLA | 46 | P61578 | |
| PWQAVKSLTQARLLS | 2526 | Q96L73 | |
| LNQWLSALRKVSINN | 661 | C9J798 | |
| SQLQVPLTWQKVSVR | 1151 | A6NNM3 | |
| SLVLQGNSKRLPLWT | 1556 | A6NNM3 | |
| SQLQVPLTWQKVSVR | 1151 | A6NJZ7 | |
| SLVLQGNSKRLPLWT | 1556 | A6NJZ7 | |
| QYPQLNLSQLLKSSW | 1156 | Q9HCM3 | |
| RVLPSWLTAQVATKN | 11 | Q9BWK5 | |
| RQIPAAASLIQTAWR | 366 | P51787 | |
| KLQPASLQSLWLQDT | 31 | Q969S2 | |
| RPLWRQESLQSVKNT | 526 | Q9NPP4 | |
| PVVKNSITKNQWLLT | 26 | Q9H3K2 | |
| TSLKTAQSSWVNLPR | 766 | Q9ULD2 | |
| LRLWPTLSKSTQQEL | 721 | Q86WG5 | |
| LWLSDNQSKALIPLQ | 396 | Q96NW7 | |
| RSNPKIWNVHSVLNV | 216 | Q9Y262 | |
| SWLSRNLEVKAQPQA | 1851 | Q9Y3R5 | |
| QIVLWDNRSNKRTPV | 356 | Q13409 | |
| VLSATINNPNLLTKW | 896 | Q5H9U9 | |
| TNSLPLRFWVNILKN | 1681 | O15031 | |
| TNSLPLRFWVNILKN | 1411 | O60486 | |
| KNTRLSVILDPNWNG | 1391 | Q7Z5P9 | |
| SLPDWTVQNGKNLTL | 41 | P16284 | |
| RLDPVSLQTLQTWNT | 381 | Q99784 | |
| VSDKWTRNQLSPQLL | 206 | O75616 | |
| QLTRKLWQSGQQVTL | 281 | Q86UT5 | |
| INLSQHSLVIKWNSP | 566 | P48552 | |
| LRRQSSSPEQQKKLW | 956 | Q8TDZ2 | |
| QRLPLNNLLASKIWT | 116 | P31644 | |
| NAILTQWNRTVKPTR | 491 | O60774 | |
| FPKQIAWNQSRTNSI | 1101 | A8MYU2 | |
| RLQTRTVKNSSSPVW | 46 | P0C869 | |
| VATNGKQRWLLSPST | 61 | Q9Y2J8 | |
| LTSNSPRLVQNCLWT | 361 | P14923 | |
| IDTSIRPWNTQNTRN | 361 | Q5SRI9 | |
| RQWEKNVPNTALTAL | 361 | P51956 | |
| VLAISTKNPLQWQAI | 161 | Q86YJ5 | |
| TKNPLQWQAISLTVI | 166 | Q86YJ5 | |
| RLKGQTTIENPLWSS | 856 | Q7Z553 | |
| PLLKLSNQWLLSTVT | 181 | P0DN82 | |
| ITTSQDLQWLVQPTL | 61 | P53539 | |
| TSALVRNWKRPSDQL | 251 | O43613 | |
| AQIRTKQLQPWQPSR | 346 | Q96A11 | |
| KLLVWNHSSLSPVQQ | 336 | Q9UM11 | |
| DLNSLIKSWLRNQPA | 2121 | Q8NCM8 | |
| RTGSWQVLQRKQSPD | 386 | Q93033 | |
| KRQPVSLDLSWTNIS | 951 | Q9Y2K7 | |
| DSPIWNFQQQSRLSK | 1686 | Q4AC94 | |
| RTKTLRNTLNPTWNE | 181 | Q14184 | |
| GLLKWRSNTSLLQQN | 621 | Q14185 | |
| AAILSRAPWSLQSVN | 26 | P10912 | |
| KQPHTTVQRLLTWGL | 16 | Q5T197 | |
| NRTKNSLTLQWKAPS | 381 | Q9Y2H6 | |
| LGNPQKSSWRLLTIN | 806 | Q8TDW7 | |
| SWQITPRNNISLVKF | 906 | Q9UHN6 | |
| VSSPLQSLQQRTWLI | 201 | P60228 | |
| QTWRLAREILTNPKS | 341 | Q9Y586 | |
| AISTKNPLQWQAISL | 216 | Q9P2E8 | |
| LNVSSLAWNKTNPDL | 486 | Q5VTH9 | |
| PSIWSKQNVGVSNRA | 51 | Q6PII3 | |
| RWVLTGTPIQNSLKD | 581 | Q14527 | |
| KRKWNSLSVIPVLNS | 301 | Q92674 | |
| LTLNWNFSSPIEKRQ | 481 | Q96MH7 | |
| SSLKNENPNVLEWLT | 1021 | Q9NZJ4 | |
| ITQIQWGSRKNLLAV | 381 | Q96RY7 | |
| SPEKLQETSNWLLSQ | 1096 | P0C0L4 | |
| PSSSNISLWNILRNN | 521 | Q9H4L5 | |
| INPSRQWQTLKQNTG | 161 | P78504 | |
| QQIPRWFNSVKLRSL | 6 | Q96E29 | |
| WLSQVQSTKRPARAI | 31 | Q9Y316 | |
| LTAQSTPNNTVWKIA | 116 | Q9NPJ8 | |
| SLKRTRNNKWFTGPQ | 431 | Q92990 | |
| PNQALTTWSILIKFN | 341 | Q9NSD7 | |
| TPAQLRQSSLELTVW | 541 | Q4VX76 | |
| SLSKLQWQKVLSSPN | 586 | Q4VX76 | |
| NWIKTQLSSQKLRGS | 166 | Q9UI12 | |
| LRTKTLRNTRNPIWN | 446 | Q9Y2J0 | |
| KTKTIRSTLNPQWNE | 211 | P17252 | |
| SRSQVPIILQWNKSS | 391 | Q8N0V4 | |
| QTWRLAREILTNPKS | 341 | Q13394 | |
| SKWIQLQQKNSPNTL | 541 | Q7Z494 | |
| FLQLQPDNSTLTWVK | 881 | Q9P212 | |
| VDSQIRSKQNWSLLP | 921 | P35251 | |
| SQLQVPLTWQKVSVR | 1151 | Q9UFD9 | |
| SLVLQGNSKRLPLWT | 1556 | Q9UFD9 | |
| QLVPSWNGSLKQLLT | 286 | Q8NEA9 | |
| RRSWLAVNQALPVSN | 751 | Q8IWB4 | |
| SPRKWQNSIRHNLTL | 111 | Q13461 | |
| QSLRPTKTESSLNWL | 221 | Q9NPR2 | |
| NLLGISWPQKTSSEQ | 1701 | Q7Z443 | |
| PLQQRTAWAISQLAT | 231 | Q68DV7 | |
| LKGNRNVTLTLSWNV | 136 | P61009 | |
| INFLKVQWSSRQLPT | 791 | O15357 | |
| PKLKASWRQLLQNSV | 406 | Q8TBK2 | |
| IVWRINRLPDKNSAS | 791 | Q8WXE9 | |
| KLWRQQTDSSLQQPV | 456 | Q8WYL5 | |
| SRAPQAWAKLQASLT | 366 | Q9C0C6 | |
| RIIQSWEKISSQQNP | 736 | P42695 | |
| ISDNLWISQRKPAIT | 226 | Q96KN2 | |
| KWPLLTVDVINQNTS | 916 | Q96JI7 | |
| QLIINFDKWSAPNLT | 1526 | O75443 | |
| RRSWLAVNQALPVSN | 751 | Q5VYP0 | |
| QRKLTWRSNPSDINV | 101 | Q9H3T3 | |
| PSKQNSLLWRANTDR | 71 | P01374 | |
| LKLISGWVSRSNDPQ | 756 | O14980 | |
| PIGSTWNTQRAFQKL | 701 | Q5TAP6 | |
| NVTAQQKWPLLRANS | 186 | Q9UID6 | |
| WKTAAPELQTNVRSQ | 31 | P82933 | |
| RRSWLAVNQALPVSN | 751 | Q5TZJ5 | |
| GKLQAASWRLQNPSR | 91 | O95210 | |
| RRSWLAVNQALPVSN | 751 | Q5VU36 | |
| STIPIKQNARRSSWS | 786 | Q12767 | |
| NPWSLQATTEKSQRI | 176 | Q9UNN4 | |
| NRLSQLQKAADPWVL | 871 | O94964 | |
| SSSEKPTVQQLQILW | 586 | Q9Y263 | |
| STNFPIIAVTLRNNW | 366 | Q8NE00 | |
| NRTLLLVGSPTWKNA | 591 | P80108 | |
| RPSNLANNTILVKWL | 341 | P22309 | |
| TRPSNLANNTILVKW | 341 | P35504 | |
| LNVTTAWKAQNPVLR | 81 | Q6H3X3 | |
| QSWILSVNPNRRLTS | 206 | Q9NXF1 | |
| PLSQITARNNVVWAL | 936 | O15040 | |
| VDTRGQPWTQTLQLK | 106 | Q9P0V8 | |
| LSSQVPLKRLLNTWT | 3151 | P78527 | |
| PLWSKIIHTLRENNQ | 1241 | Q9P2E3 | |
| PSATIQETQQWLLKN | 366 | Q9NZI7 | |
| RRPWLSQLSNKKQSN | 46 | P42681 | |
| SNSIKNQELPLRTTW | 166 | A6NK53 | |
| RPIWSRNAVKANISV | 261 | Q9Y5Q8 | |
| VWSRLLKPNSSLSNL | 41 | Q5T742 | |
| LNVTTAWKAQNPVLR | 81 | Q9BZM5 | |
| LSQPKFWAIQTSALI | 376 | Q6P3X3 | |
| PNLTQWIRTISQQIK | 1241 | Q8IWV8 | |
| NPNWQQSDLRLTRIT | 156 | Q6BDS2 | |
| LQKLNSILTQPWRLH | 976 | Q69YN4 | |
| LPLTWVLQNQQTFLK | 1171 | Q9Y4A5 | |
| SSWQVKDNRVRQLPT | 311 | Q08AF3 | |
| SGRITNWLVLKNLTP | 1776 | Q8NDV7 | |
| QELNKSLSTWQPTLL | 1166 | Q14202 | |
| APLKVWQLQDLSFQT | 316 | Q9NYU2 | |
| TRPSNLANNTILVKW | 341 | P22310 | |
| NRWRASQLIKSIPAS | 781 | O94832 |